Bethanechol chloride is a drug used in the treatment of dysphagia associated with schlerodermia, gastric atony, and postoperative urinary retention.
Bethanechol chloride is one of a group of choline esters, which produce the effects of stimulation of parasympathetic nervous system. This results in the release of acetylcholine at the nerve endings; it is a neurotransmiiter. Although acetylcholine can be administered therapeutically, its clinical effect is greatly curtailed by its instability when it is introduced into the body. Since Bethanechol chloride is not hydrolized by cholinesterase, it is more stable than acetylcholine in the blood stream and body tissues.